|Table of Contents|

17β-estradiol promotes proliferation, migration and TFF1 secretion in papillary thyroid cancer K-1 cells



Research Field:
Publishing date:



17β-estradiol promotes proliferation, migration and TFF1 secretion in papillary thyroid cancer K-1 cells


LIAO Lingyao DAI Yujie ZHAO Tingting LIU Zhimin


17&beta-estradiol papillary thyroid cancer trefoil factor family 1 estrogen receptor

R347.91; R730.23; R736.1

Objective     To investigate whether 17β-estradiol (E2) can stimulate the proliferation, migration, and secretion of trefoil factor family 1 (TFF1) in papillary thyroid cancer K-1 cells and explore the molecular mechanisms. Methods     ELISA was used to detect the content of TFF1 in the supernatant of K-1 cells after the treatment of E2, propylpyrazoletriol (PPT, ERα agonist) or diarylpropionitrile (DPN, ERβ agonist). The expression of ERα and ERβ in the untreated cells was measured by Western blotting. ERα siRNA and ERβ siRNA by RNA interference were designed and synthesized, and the change of TFF1 was measured by ELISA again after the transfection. The interaction between TFF1 promoter and ER was evaluated by chromatin immunoprecipitation analysis (CHiP). The proliferation and migration were detected in the K-1 cells after E2 treatment by MTT assay and Transwell chamber test respectively. Results    After E2 treatment, the TFF1 content in the supernatant of K-1 cells was increased gradually, reached peak at 24 h, and then declined slowly. PPT treatment enhanced the secretion of TFF1 but DPN decreased it in the K-1 cells. Transfection of ERα siRNA obliterated the inductive effect of E2 on the secretion of TFF1, but that of ERβ siRNA increased the inductive effect in the K-1 cells. Western blotting showed that the expression level of ERα was higher than that of ERβ in the K-1 cells. ChIP results confirmed that ERα protein was bound to the promoter of TFF1 gene in K-1 cells. E2 treatment promoted cell proliferation and improved cell migration in the K-1 cells. Conclusion     E2 induces the expression and secretion of TFF1 in K-1 cells through ERα-dependent manner, and thus promotes the proliferation and migration of the cells.


[1]RAHBARI R, ZHANG L, KEBEBEW E. Thyroid cancer gender disparity[J]. Future Oncol, 2010, 6: 1771-1779. DOI: 10.2217/fon.10.127.
[2]PERRY J K, KANNAN N, GRANDISON P M, et al. Are trefoil factors oncogenic?[J].Trends in Endocrinol Metab, 2008, 19 (2): 74-81. DOI: 10.1016/j.tem.2007.10.003.
[3]PELDEN S, INSAWANG T, THUWAJIT C, et al. The trefoil factor 1 (TFF1) protein involved in doxorubicin?induced apoptosis resistance is upregulated by estrogen in breast cancer cells[J]. Oncol Rep, 2013, 30(3): 1518-1526. DOI: 10.3892/or.2013.2593.
[4]LA ROSA P, PELLEGRINI M, TOTTA P, et al. Xenoestrogens alter estrogen receptor (ER) α intracellular levels[J]. PLoS One, 2014, 9(2): e88961. DOI: 10.1371/journal.pone.0088961.
[5]GAO Q G, CHAN H Y, MAN C W, et al. Differential ERα-mediated rapid estrogenic actions of ginsenoside Rg1 and estren in human breast cancer MCF-7 cells[J]. J Steroid Biochem Mol Biol, 2014, 141: 104-112. DOI: 10.1016/j.jsbmb.2014.01.014.
[6]METIVIER R, PENOT G, HUBNER M R, et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter[J]. Cell, 2003, 115(6): 751-763.
[7]莫小梅,朱平,刘智敏,等. 17β雌二醇对人甲状腺乳头状癌BCPAP细胞Hsp27表达的影响及作用机制[J]. 基础医学与临床,2016,36(10):1348-1353.DOI:10.16352/j.issn.1001-6325.2016.10.005.
MO X M,ZHU P,LIU Z M,et al.Effect of 17β-estradiol on the expression of Hsp27 by papillary thyroid cancer BCPAP cells and its mechanism[J].Basic Clin Med, 2016,36(10):1348-1353.DOI:10.16352/j.issn.1001-6325.2016.10.005.
[8]TAUPIN D, PODOLSKY D K. Trefoil factors: initiators of mucosal healing[J]. Nat Rev Mol Cell Biol, 2003, 4(9):721732. DOI: 10.1038/nrm1203.
[9]REGALO G. Trefoil factors: from ulceration to neoplasia[J]. Cell Mol Life Sci, 2005, 62(24): 2910-2915. DOI: 10.1007/s00018-005-5478-4.
[10]EMAMI S. Trefoil factor family (TFF) peptides and cancer progression[J]. Peptides, 2004, 25(5): 885-898. DOI: 10.1016/j.peptides.2003.10.019.
[11]BARON S, ESCANDE A, ALBROLA G, et al. Estrogen receptor α and the activating protein-1 complex cooperate during insulinlike growth factor-I-induced transcriptional activation of the pS2/TFF1 gene[J]. J Biol Chem, 2007, 282(16): 11732-11741. DOI:10.1074/jbc.M610079200.
[12]BARKHEM T, HALDOS-N L A, GUSTAFSSON J A, et al. PS2 gene expression in HepG2 cells: complex regulation through crosstalk between the estrogen receptor, an estrogenresponsive element, and the activator protein 1 response element[J]. Mol Pharmacol, 2002, 61(6): 1273-1283. DOI: 10.1124/mol.61.6.1273.
[13]PLANEY S L, KUMAR R, ARNOTT J A. Estrogen receptors (ERα versus ERβ): friends or foes in human biology?[J].J Recept Signal Transduct Res, 2014, 34 (1): 1-5. DOI: 10.3109/10799893.2013.853188.
[14]CHANG E C, FRASOR J, KOMM B, et al. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells[J]. Endocrinology, 2006, 147 (10): 4831-4842. DOI:10.1210/en.2006-0563.
[15]WILLIAMS C, EDVARDSSON K, LEWANDOWSKI S A, et al. A genomewide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells[J]. Oncogene, 2008, 27 (7): 1019-1032. DOI: 10.1038/sj.onc.1210712.
[16]BERRY M, NUNEZ A M, Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence[J]. J Biol Chem, 1989, 86 (4): 1218-1222.
[17]MATTHEWS J, WIHL-N B, TUJAGUE M, et al. Estrogen receptor (ER) beta modulates ER alphamediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters[J]. Mol Endocrinol, 2006, 20(3): 534-543. DOI: 10.1210/me.2005-0140.


Last Update: 2017-09-04